RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kobayashi Pharmaceutical Co Stock

Kobayashi Pharmaceutical Co ROE 2024

Kobayashi Pharmaceutical Co ROE

0.1

Ticker

4967.T

ISIN

JP3301100008

WKN

920477

In 2024, Kobayashi Pharmaceutical Co's return on equity (ROE) was 0.1, a -1.85% increase from the 0.1 ROE in the previous year.

Kobayashi Pharmaceutical Co Aktienanalyse

What does Kobayashi Pharmaceutical Co do?

Kobayashi Pharmaceutical Co Ltd is a Japanese company that specializes in the production of health products. Kobayashi Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Kobayashi Pharmaceutical Co's Return on Equity (ROE)

Kobayashi Pharmaceutical Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Kobayashi Pharmaceutical Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Kobayashi Pharmaceutical Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Kobayashi Pharmaceutical Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Kobayashi Pharmaceutical Co stock

What is the ROE (Return on Equity) of Kobayashi Pharmaceutical Co this year?

The ROE of Kobayashi Pharmaceutical Co this year is 0.1 undefined.

How has the Return on Equity (ROE) of Kobayashi Pharmaceutical Co developed compared to the previous year?

The ROE of Kobayashi Pharmaceutical Co has increased by -1.85% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Kobayashi Pharmaceutical Co?

A high ROE indicates that Kobayashi Pharmaceutical Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Kobayashi Pharmaceutical Co?

A low ROE can indicate that Kobayashi Pharmaceutical Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Kobayashi Pharmaceutical Co affect the company?

A change in ROE (Return on Equity) of Kobayashi Pharmaceutical Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Kobayashi Pharmaceutical Co?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Kobayashi Pharmaceutical Co?

Some factors that can influence Kobayashi Pharmaceutical Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Kobayashi Pharmaceutical Co pay?

Over the past 12 months, Kobayashi Pharmaceutical Co paid a dividend of 101 JPY . This corresponds to a dividend yield of about 1.9 %. For the coming 12 months, Kobayashi Pharmaceutical Co is expected to pay a dividend of 107.77 JPY.

What is the dividend yield of Kobayashi Pharmaceutical Co?

The current dividend yield of Kobayashi Pharmaceutical Co is 1.9 %.

When does Kobayashi Pharmaceutical Co pay dividends?

Kobayashi Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.

How secure is the dividend of Kobayashi Pharmaceutical Co?

Kobayashi Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kobayashi Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 107.77 JPY are expected. This corresponds to a dividend yield of 2.03 %.

In which sector is Kobayashi Pharmaceutical Co located?

Kobayashi Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Kobayashi Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kobayashi Pharmaceutical Co from 3/1/2025 amounting to 59 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Kobayashi Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/1/2025.

What was the dividend of Kobayashi Pharmaceutical Co in the year 2023?

In the year 2023, Kobayashi Pharmaceutical Co distributed 90 JPY as dividends.

In which currency does Kobayashi Pharmaceutical Co pay out the dividend?

The dividends of Kobayashi Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kobayashi Pharmaceutical Co

Our stock analysis for Kobayashi Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kobayashi Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.